High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and efficacy of quetiapine in sub-optimally responding
patients with DSM-IV schizophrenia using a double blind, randomized 12-week trial comparing
oral doses of 1200 mg/d to 600 mg/d of quetiapine.